Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture

M Rostock, K Jaroslawski, C Guethlin, R Ludtke, S Schröder, H H Bartsch, M Rostock, K Jaroslawski, C Guethlin, R Ludtke, S Schröder, H H Bartsch

Abstract

Purpose. Chemotherapy-induced peripheral neuropathy (CIPN) is a common and dose-limiting side effect of cytostatic drugs. Since there are no proven therapeutic procedures against CIPN, we were interested to define the role of electroacupuncture (EA) from which preliminary data showed promising results. Methods. In a randomized trial with a group sequential adaptive design in patients with CIPN, we compared EA (LV3, SP9, GB41, GB34, LI4, LI11, SI3, and HT3; n = 14) with hydroelectric baths (HB, n = 14), vitamin B1/B6 capsules (300/300 mg daily; VitB, n = 15), and placebo capsules (n = 17). The statistical power in this trial was primarily calculated for proving EA only, so results of HB and VitB are pilot data. Results. CIPN complaints improved by 0.8 ± 1.2 (EA), 1.7 ± 1.7 (HB), 1.6 ± 2.0 (VitB), and 1.3 ± 1.3 points (placebo) on a 10-point numeric rating scale without significant difference between treatment groups or placebo. In addition no significant differences in sensory nerve conduction studies or quality of life (EORTC QLQ-C30) were found. Conclusions. The used EA concept, HB, and VitB were not superior to placebo. Since, contrary to our results, studies with different acupuncture concepts showed a positive effect on CIPN, the effect of acupuncture on CIPN remains unclear. Further randomized, placebo controlled studies seem necessary. This trial is registered with DRKS00004448.

Figures

Figure 1
Figure 1
Flow chart.
Figure 2
Figure 2
CIPN perceived symptom severity day 0, day 21, and day 84 (severity rated on a 10-point numerical rating scale (NRS); all values are mean ± SD).

References

    1. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Seminars in Oncology. 2006;33(1):15–49.
    1. Postma TJ, Heimans JJ. Grading of chemotherapy-induced peripheral neuropathy. Annals of Oncology. 2000;11(5):509–513.
    1. Albers J, Chaudhry V, Cavaletti G, Donehower R. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database of Systematic Reviews. 2007;(1)CD005228
    1. Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clinical Pharmacology and Therapeutics. 2011;90(3):377–387.
    1. Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Supportive Care in Cancer. 2004;12(9):619–625.
    1. Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clinical Journal of Oncology Nursing. 2007;11(6):901–913.
    1. Wickham R. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing. 2007;11(3):361–376.
    1. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. European Journal of Cancer. 2008;44(11):1507–1515.
    1. Brunelli B, Gorson KC. The use of complementary and alternative medicines by patients with peripheral neuropathy. Journal of the Neurological Sciences. 2004;218(1-2):59–66.
    1. Stux G, Stiller N, Pomeranz B, editors. Akupunktur—Lehrbuch und Atlas. 5th edition. Berlin, Germany: Springer; 1999.
    1. Abuaisha BB, Costanzi JB, Boulton AJM. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Research and Clinical Practice. 1998;39(2):115–121.
    1. Ahn AC, Bennani T, Freeman R, Hamdy O, Kaptchuk TJ. Two styles of acupuncture for treating painful diabetic neuropathy—a pilot randomised control trial. Acupuncture in Medicine. 2007;25(1-2):11–17.
    1. Wang YP, Ji L, Li JT, Pu JQ, Liu FJ. Effects of acupuncture on diabetic peripheral neuropathies. Zhongguo Zhen Jiu. 2005;25(8):542–544.
    1. Schröeder S, Remppis A, Greten T, Brazkiewicz F, Morcos M, Greten HJ. Quantification of acupuncture effects on peripheral neuropathy of unknown and diabetic cause by nerve conduction studies. Journal of Acupuncture and Tuina Science. 2008;6(5):312–314.
    1. Galantino MLA, Eke-Okoro ST, Findley TW, Condoluci D. Use of noninvasive electroacupuncture for the treatment of HIV-related peripheral neuropathy: a pilot study. Journal of Alternative and Complementary Medicine. 1999;5(2):135–142.
    1. Phillips KD, Skelton WD, Hand GA. Effect of acupuncture administered in a group setting on pain and subjective peripheral neuropathy in persons with human immunodeficiency virus disease. Journal of Alternative and Complementary Medicine. 2004;10(3):449–455.
    1. Schröder S, Liepert J, Remppis A, Greten JH. Acupuncture treatment improves nerve conduction in peripheral neuropathy. European Journal of Neurology. 2007;14(3):276–281.
    1. Lee H, Schmidt K, Ernst E. Acupuncture for the relief of cancer-related pain—a systematic review. European Journal of Pain. 2005;9(4):437–444.
    1. Minton O, Higginson IJ. Electroacupuncture as an adjunctive treatment to control neuropathic pain in patients with cancer. Journal of Pain and Symptom Management. 2007;33(2):115–117.
    1. Meng X, Zhang Y, Li A, et al. The effects of opioid receptor antagonists on electroacupuncture-produced anti-allodynia/hyperalgesia in rats with paclitaxel-evoked peripheral neuropathy. Brain Research. 2011;1414:58–65.
    1. Grober J, editor. Klinisches Lehrbuch der Physikalischen Therapie. Stuttgart, Germany: Gustav Fischer; 1963.
    1. Ang CD, Alviar MJM, Dans AL, et al. Vitamin B for treating peripheral neuropathy. Cochrane Database of Systematic Reviews. 2008;(3)CD004573
    1. Bauer P, Kohne K. Evaluation of experiments with adaptive interim analyses. Biometrics. 1994;50(4):1029–1041.
    1. Hui KKS, Nixon EE, Vangel MG, et al. Characterization of the “deqi” response in acupuncture. BMC Complementary and Alternative Medicine. 2007;7, article 33
    1. National Cancer Institute (NCI) Cancer Therapy Evaluation Program. Common Toxicity Criteria Manual: Common Toxicity Criteria, Version 2.0. NCI; 1999.
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute. 1993;85(5):365–376.
    1. Maurer W, Hothorn LA, Lehmacher W. Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses. In: Vollmar J, editor. Biometrie in der Chem-Pharm Industrie. Vol. 6. Stuttgart, Germany: Fischer; 1995. pp. 2–18.
    1. Unnebrink K, Windeler J. Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Statistics in Medicine. 2001;20(24):3931–3946.
    1. Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE. 2008;3(8, article e3081)
    1. Littner Y, Mimouni FB, Dollberg S, Mandel D. Negative results and impact factor: a lesson from neonatology. Archives of Pediatrics and Adolescent Medicine. 2005;159(11):1036–1037.
    1. Wong R, Sagar S. Acupuncture treatment for chemotherapy-induced peripheral neuropathy—a case series. Acupuncture in Medicine. 2006;24(2):87–91.
    1. Xu W-R, Hua B-J, Hou W, Bao Y-J. Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs. Zhongguo Zhen Jiu. 2010;30(6):457–460.
    1. Schroeder S, Meyer-Hamme G, Epplée S. Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography. Acupuncture in Medicine. 2012;30(1):4–7.
    1. Bao T, Zhang R, Badros A, Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report. Pain Research and Treatment. 2011;2011:4 pages.920807
    1. Donald GK, Tobin I, Stringer J. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupuncture in Medicine. 2011;29(3):230–233.
    1. Alimi D, Rubino C, Pichard-Léandri E, Fermand-Brulé S, Dubreuil-Lemaire M-L, Hill C. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. Journal of Clinical Oncology. 2003;21(22):4120–4126.
    1. Raffe M. Priciples of peripheral nerve repair and regeneration. In: Newton C, Nunamaker D, editors. Textbook of Small Animal Orthopaedics. Philadelphia, Pa, USA: Lippincott; 1985.
    1. Weis J, Moser M, Bartsch H. Goal-oriented evaluation of inpatient rehabilitation programs for women with breast cancer (ZESOR-Study) In: Jaeckel W, Bengel J, Herdt J, editors. Research in Rehabilitation: Results of a Research Network in Southwest Germany. Stuttgart, Germany: Schattauer; 2006. pp. 162–171.
    1. Cavaletti G, Cornblath DR, Merkies IS, et al. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Annals of Oncology. 2013;24(2):454–462.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅